Home › Therapeutic areas › Infectious Disease › Mycobacterium abscessus Lung Disease
Mycobacterium abscessus Lung Disease (1 companies)
Companies with an active program in Mycobacterium abscessus Lung Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics | HematologyInfectious Disease+1 Rare | 1 | Phase 2 | $151M | 6 |
No companies match.